Preclinical studies have demonstrated that triple receptor agonists (RAs) activating all three receptors (GLP-1, GIP, and GCG) produce more pronounced weight loss than dual agonists targeting only two receptors [6]
Botulinum toxin was used to improve dynamic wrinkles, while polynucleotides such as PolyPhil was used to improve skin texture
It has been proven that the native peptide GLP-1, GLP-1 receptor agonists and GIP-1 receptor agonists can cross the blood-brain barrier (BBB) (61)
Therapies based on glucagon-like peptide-1 (GLP-1) reduce rates of cardiovascular and chronic kidney disease in people with type 2 diabetes and/or obesity, with ongoing clinical trials investigating their effects in people with metabolic liver disease, arthritis, and both substance use and neurodegenerative disorders
Recall periods appeared in final position in 87% of items, and 6% each for medial and initial position
STATs coverage of chronic health issues is supported by a grant from Bloomberg Philanthropies